Sub-Domain 6 · Behavioral Health and SUD Delivery

SD6 documents the behavioral-health and SUD delivery architecture for PA-3 — Pennsylvania's structurally distinctive Behavioral HealthChoices county-based carve-out (5 BH-MCOs across 67 counties with Community Behavioral Health exclusively in Philadelphia County, contracted by the City of Philadelphia DBHIDS since February 1997 as one of the first city-operated BH-MCOs in the U.S.), the MHPAEA federal parity framework with the 2024 Final Rule under Trump-administration partial non-enforcement (Tri-Agency statement May 15, 2025; ERIC v. DOL/HHS/Treasury in abeyance before Judge Timothy J. Kelly D.D.C.; 2013 Final Rule and CAA 2021 NQTL obligations remain operative), the SAMHSA 42 C.F.R. Part 8 OTP Final Rule, the MAT Act / Section 1262 CAA 2023 DATA-Waiver elimination, the DEA-HHS permanent telemedicine flexibility for buprenorphine OUD prescribing, the 988 Lifeline architecture, and PA Act 98 of 2022 telehealth permanence. Heavy cross-reference surface with D3 SD1 Mental Health Infrastructure, D3 SD3 Community Mental Health and SUD Treatment, D3 SD5 Mental Health Parity, and D3 SD6 Forensic Mental Health. The MC56 substantive single-MCO innovation plus structural concentration-risk Both/And operates here; the MHPAEA Both/And at [G21-SD6-02](https://github.com/square-party/square-party-site/blob/main/reference-info/verified-pa3-domain-content/D21-healthcare-delivery/D21_healthDeliv_verified_2026-05-11.md#g21-sd6-02) mirrors the parallel SD3 [G21-SD3-04](https://github.com/square-party/square-party-site/blob/main/reference-info/verified-pa3-domain-content/D21-healthcare-delivery/D21_healthDeliv_verified_2026-05-11.md#g21-sd3-04) commercial-side Both/And.

Legal Architecture

Constitutional foundation

Behavioral-health and SUD delivery operates under Article I § 8 (Commerce Clause; Spending Clause; General Welfare Clause; federal MHPAEA framework, SAMHSA grants, Medicare / Medicaid BH benefits, federal SUD treatment regulatory architecture) and 10th Amendment (state SUD treatment licensing and BH-MCO contracting authority). ERISA preempts state regulation of self-funded employer plans for MHPAEA enforcement purposes (cross-reference SD3 G21-SD3-04).

Federal statutory layer

MHPAEA. 29 U.S.C. § 1185a; 42 U.S.C. § 300gg-26. Requires group health plans, individual market plans, Medicare Advantage, and Medicaid managed care to provide MH/SUD benefits at parity with medical/surgical — same financial requirements (deductibles, copays, coinsurance), treatment limitations, and non-quantitative treatment limitations (NQTLs including prior authorization, network access standards, medical-necessity criteria). Tri-Agency joint enforcement: DOL EBSA, HHS, Treasury. Consolidated Appropriations Act 2021 (CAA 2021) § 203 added NQTL comparative analysis requirement.

MHPAEA 2024 Final Rule. 89 Fed. Reg. 77586 (September 23, 2024). Tri-Agency final rule effective November 22, 2024 with staggered applicability: plan years on/after January 1, 2025 (initial compliance) and January 1, 2026 (additional standards including meaningful benefits, discriminatory factors prohibition, relevant data evaluation, comparative analyses). New regulations on content of comparative analyses, evaluation of outcomes data, prohibitions on discriminatory factors and evidentiary standards, requirements for meaningful benefits, and effects of non-compliance. ERIC v. DOL/HHS/Treasury filed in U.S. District Court for the District of Columbia (Judge Timothy J. Kelly) challenging the Final Rule; case in abeyance May 12, 2025. Trump administration partial non-enforcement policy announced May 9-15, 2025 covering portions of the Final Rule "new in relation to 2013 Final Rule" until final decision in ERIC litigation plus 18 months. 2013 Final Rule remains operative; CAA 2021 NQTL comparative analysis requirements remain operative; statute itself remains in place. March 3, 2026 Tri-Agencies Fourth Report to Congress documents shift in enforcement tone with DOL "not as active as previously" while state enforcement growing.

SAMHSA 42 C.F.R. Part 8 OTP Final Rule. 89 Fed. Reg. 7528 (February 2, 2024); effective April 2, 2024; compliance October 2, 2024; correction effective February 23, 2026 (91 Fed. Reg. 7456). Codifies COVID-era flexibilities permanently: take-home doses up to 28 days methadone for stable patients / 14 days for less stable; telehealth screening for buprenorphine initiation; audio-only and audio-visual telehealth platforms for buprenorphine treatment subject to HIPAA-compliance; in-person components of full exam may be scheduled within first 14 days. Removes all language and rules pertaining to DATA Waiver per CAA 2023.

MAT Act / § 1262 of Consolidated Appropriations Act 2023 (P.L. 117-328). Removed federal requirement for practitioners to submit Notice of Intent (DATA Waiver) to prescribe buprenorphine for OUD treatment; eliminated patient caps; eliminated discipline restrictions; eliminated counseling certification requirements. Practitioners with current DEA Schedule III registration may prescribe buprenorphine for OUD subject to applicable state law.

DEA-HHS Telemedicine Flexibility Final Rule (2025). Finalized telemedicine flexibility regulations making buprenorphine-related telemedicine prescribing permanent.

National Suicide Hotline Designation Act of 2020 (P.L. 116-172). Authorized 988 Suicide and Crisis Lifeline as nationwide 3-digit dialing code; SAMHSA implementation administered through Vibrant Emotional Health contractor; state-level crisis-line architecture coordinates with 988 routing.

42 C.F.R. Part 2 SUD Treatment Record Confidentiality. Federal SUD treatment record confidentiality framework; harmonized with HIPAA under CAA 2021 amendments to permit single patient consent for full HIPAA-style use and disclosure; 42 C.F.R. Part 2 Final Rule (February 2024) implements harmonization.

CCBHC Medicaid Demonstration. § 223 of Protecting Access to Medicare Act 2014; expanded by CCBHC Expansion Act. Authorizes Certified Community Behavioral Health Clinic Medicaid demonstration with PPS reimbursement architecture; SAMHSA administers CCBHC expansion grants.

One Big Beautiful Bill Act of 2025 (P.L. 119-21) behavioral-health-affecting provisions. OBBBA Sections 71107 / 71109 / 71115 / 71117 / 71119 affect Medicaid managed care including BH carve-out architecture (cross-reference SD2 G21-SD2-02). MCO-tax tightening (Section 71117) effective July 4, 2025 with three-year CMS transition window affects BH-MCO architecture (CBH is a Medicaid BH-MCO subject to MCO-tax architecture).

Federal agency layer

SAMHSA. Administers federal MH and SUD grant architecture; Center for Substance Abuse Treatment administers OTP certification; Center for Mental Health Services administers MH grant programs and 988 implementation; CCBHC expansion grants. Administrative vulnerability: HIGH at Trump-administration SAMHSA policy posture. Cross-reference D3 SD1 for SAMHSA capacity erosion in 2025-2026 (AHA reorganization March 27, 2025; greater than 50% staff reduction; PAIMI administration team laid off; January 14-15, 2026 grant-termination-and-reversal episode).

DOL EBSA, HHS, Treasury (Tri-Agency MHPAEA enforcement). Joint MHPAEA enforcement; ERISA enforcement for self-funded employer plans (DOL EBSA); Medicaid managed care oversight including BH carve-out architectures (CMS); Medicare Advantage MH/SUD coverage oversight (CMS). Administrative vulnerability: HIGH at 2024 Final Rule non-enforcement disposition.

Drug Enforcement Administration. Administers Schedule III registration architecture for buprenorphine OUD prescribing post-MAT Act; jointly finalized telemedicine flexibility permanent regulations with HHS.

Vibrant Emotional Health (988 contractor). Administers 988 Suicide and Crisis Lifeline operational architecture under SAMHSA contract.

State statutory and agency layer

Pennsylvania Mental Health Procedures Act. 50 P.S. § 7101 et seq. Governs involuntary mental health treatment (§§ 302/303/304/305 commitment), voluntary inpatient psychiatric care, and Mental Health Review Officer architecture. Cross-reference D3 SD2 Civil Commitment for substantive analysis.

Pennsylvania Mental Health Parity Act (PA Act 50 of 2004). 40 P.S. § 908-1 et seq. PA state MHPAEA implementation for commercial plans regulated under PA insurance code (cross-reference SD3 G21-SD3-04). PA Insurance Department enforcement authority on PA-regulated commercial plans; ERISA-preempted self-funded plans federally enforced only.

PA Act 98 of 2022 (Telehealth permanence). Permanently removed PA DHS regulations prohibiting payment for audio-only telehealth in outpatient psychiatric clinics and outpatient drug-and-alcohol clinic services. Practitioners no longer need waiver requests for audio-only telehealth when delivered in accordance with DHS telehealth bulletins. PA also defined telehealth within OTP rules to explicitly include HIPAA-compliant video and audio-only platforms.

Pennsylvania Behavioral HealthChoices program. Pennsylvania's Medicaid behavioral-health carve-out architecture; each county assigned to a single designated BH-MCO based on county of residence.

PA Department of Human Services Office of Mental Health and Substance Abuse Services (OMHSAS). Administers Pennsylvania Medicaid behavioral-health architecture; oversees county BH-MCO contracts (CBH, CCBH, PerformCare, Magellan Behavioral Health, Value Behavioral Health).

PA Department of Drug and Alcohol Programs (DDAP). Licenses SUD treatment facilities; coordinates with federal SAMHSA; administers state-level SUD funding architecture.

PA Insurance Department. Enforces PA Mental Health Parity Act on PA-regulated commercial plans. Commissioner: Michael Humphreys.

Local statutory and agency layer

Philadelphia Code Title 6 — Health. Authorizes Philadelphia DBHIDS operational architecture; CBH contracting through DBHIDS.

Philadelphia Department of Behavioral Health and Intellectual disAbility Services (DBHIDS). 1101 Market Street, Philadelphia, PA 19107. Contracts CBH as Philadelphia's single BH-MCO under PA Behavioral HealthChoices carve-out architecture; administers Philadelphia's behavioral-health-and-intellectual-disability service system; coordinates with PA OMHSAS, PA DDAP, and federal SAMHSA. Interim Commissioner since April 16, 2024: Marquita C. Williams per the verified D3 file.

Community Behavioral Health (CBH). 801 Market Street, 7th Floor, Philadelphia, PA 19107. 501(c)(3) nonprofit corporation; city-of-Philadelphia-contracted single BH-MCO since February 1997; one of the first city-operated BH-MCOs in the U.S. CBH provides behavioral-health Medicaid managed care for approximately 420,000 Medicaid recipients in Philadelphia per DBHIDS; 100,700+ used CBH services in 2023 with total expenditures of $860,000,000+. 2018 budget over $900M; one of top eleven Philadelphia non-profits by income per Pew Charitable Trusts. CEO: Donna E.M. Bailey, MSEd, MBA. Administrative vulnerability: MODERATE — single-MCO architecture means no inter-plan-competition pressure.

PA-3 SUD treatment infrastructure. OTP methadone clinics operating in PA-3; office-based buprenorphine prescribing at FQHCs (Philadelphia FIGHT, Puentes de Salud, FPCN, RHD per SD5); SUD treatment facilities licensed by DDAP.

PA-3 psychiatric inpatient infrastructure. Friends Hospital (4641 Roosevelt Boulevard); Belmont Behavioral Health (4200 Monument Road); inpatient psychiatric departments at Penn (HUP, Penn Presbyterian, Pennsylvania Hospital), Temple, Jefferson, and CHOP (pediatric); Horsham Clinic (suburban; cross-county boundary).

Cross-cutting structural features

Three structural features recur across the SD6 constituent profiles.

First, the CBH single-MCO carve-out architecture. CBH operates as the sole BH-MCO for all approximately 420,000 Philadelphia Medicaid recipients with no member choice in BH-MCO at the county level. The carve-out architecture has produced documented innovation (school-based BH since 2003; Evidence-based Practice and Innovation Center 2013; CCBHC integration; D-SNP behavioral integration; CHC Team for senior 65+ and permanent-disability members) and operates as a single point of accountability whose operational disruption would flow through to the entire Philadelphia Medicaid BH-enrolled population with no alternative BH-MCO available. MC56 Both/And captures both halves.

Second, the MHPAEA non-enforcement layer. The 2024 Final Rule's new provisions are under partial non-enforcement until ERIC litigation resolves plus 18 months. The 2013 Final Rule plus CAA 2021 NQTL comparative-analysis obligations remain operative. State enforcement (PA Insurance Department on PA-regulated commercial plans) is growing per the March 3, 2026 Tri-Agencies Fourth Report. MHPAEA Both/And at G21-SD6-02 captures substantive federal parity framework continuing operative AND structural enforcement administrative vulnerability through 2026-2027.

Third, the federal SAMHSA-OTP-MAT-Act-telemedicine architectural simplification. SAMHSA 42 C.F.R. Part 8 plus MAT Act DATA-Waiver elimination plus DEA-HHS permanent telemedicine flexibility plus PA Act 98 audio-only telehealth permanence collectively simplify office-based buprenorphine prescribing in ways that materially reduce the workforce-access bottleneck for OUD treatment capacity in PA-3.

Constituent profiles

These profiles illustrate the structural features above. The pathways are drawn from current federal and PA statute, the verified CBH operational data, and documented PA-3 BH delivery architecture; the people are composites.

Profile 1: Commercial-insurance enrollee navigating MHPAEA non-enforcement layer in South Philadelphia (MHPAEA Both/And)

Constituent type: working-age PA-3 resident with self-funded ERISA employer-sponsored commercial coverage; income approximately $68,000; single household; depression diagnosis requiring outpatient psychiatry plus therapy; South/Southwest sub-area. Triggering event: new onset depression requiring sustained outpatient psychiatric care; insurance prior authorization requirements operative.

Pathway through the institutional system. Constituent accesses plan portal; finds limited in-network psychiatrist options (8-12 week waitlist common per documented patterns); finds therapist with shorter waitlist; encounters NQTL prior authorization for medication management. MHPAEA 2013 Final Rule baseline operative requiring NQTL comparative analysis; 2024 Final Rule additional standards (meaningful benefits, discriminatory factors prohibition, relevant data evaluation) effective November 22, 2024 but Trump administration partial non-enforcement policy May 9-15, 2025 covers portions applicable for 2025 and 2026 plan years. ERISA-preempted self-funded plan; PA Insurance Department lacks jurisdiction; federal enforcement (DOL EBSA plus HHS plus Treasury joint) operates under non-enforcement disposition for 2024 Final Rule additions. Constituent may pursue MHPAEA complaint at askebsa.dol.gov; private MHPAEA claim through ERISA § 502(a).

Outcome. Constituent receives covered MH services at MHPAEA-2013-baseline parity but at delayed access; 2024 Final Rule additional protections operate under non-enforcement disposition. The MHPAEA Both/And operates: substantive federal parity framework continues operative AND structural enforcement administrative vulnerability operates at meaningful magnitude through 2026-2027 trajectory.

Profile 2: OUD patient navigating office-based buprenorphine MAT in West Philadelphia

Constituent type: working-age PA-3 resident; OUD diagnosis; HealthChoices Medicaid (Group VIII expansion; income approximately $24,000); West Philadelphia Core sub-area. Triggering event: decision to seek MAT after period of unmanaged OUD; primary care provider initiates buprenorphine prescribing post-MAT-Act-elimination of waiver requirement.

Pathway through the institutional system. Constituent presents at FQHC primary care (Philadelphia FIGHT or FPCN per SD5 cross-reference); primary care provider with DEA Schedule III registration evaluates for buprenorphine OUD prescribing; no DATA-Waiver required per MAT Act / Section 1262 CAA 2023; provider may initiate buprenorphine via audio-only or audio-visual telehealth per SAMHSA 42 C.F.R. Part 8 Final Rule plus DEA-HHS permanent telemedicine flexibility; CBH BH-MCO architecture administers buprenorphine formulary authorization (cross-reference SD2 G21-SD2-06 BH-PH coordination architecture). PA Act 98 of 2022 permits audio-only telehealth in PA outpatient drug-and-alcohol clinic services. 42 C.F.R. Part 2 SUD record confidentiality protects SUD treatment information; CAA 2021 harmonization with HIPAA permits single consent.

Outcome. Constituent receives buprenorphine OUD treatment through office-based primary care provider with telehealth flexibility; SUD treatment continuity supported by PA Act 98 audio-only telehealth allowance plus DEA-HHS permanent telemedicine flexibility. The substantive federal SAMHSA architecture plus MAT Act simplification operates well at this delivery layer; structural risk is at CBH formulary authorization and at OBBBA Section 71119 work-requirement architecture if working hours fall below threshold (cross-reference SD2 G21-SD2-02).

Profile 3: Child navigating school-based BH under CBH architecture in North Philadelphia (MC56 substantive)

Constituent type: PA-3 child age 11 enrolled in Philadelphia School District (cross-reference D11 SD7 SDP architecture); HealthChoices Medicaid; ADHD and anxiety diagnosis; North/Northwest Core sub-area; family income approximately $34,000.

Pathway through the institutional system. School counselor identifies BH need; refers to CBH school-based BH program (launched 2003); CBH-contracted school-based BH clinician delivers outpatient counseling and care coordination at the school building; medication management referral to community psychiatrist within CBH provider network; coordination with primary care pediatrician at FQHC or PDPH clinic. Cross-reference D3 SD4 Children's Behavioral Health for substantive children's BH architecture and the post-ESSER plus BSCA terminated funding flow-through.

Outcome. Child receives BH services at the school building reducing access barriers. The CBH school-based architecture is the substantive-contribution dimension of MC56 — the city-operated single BH-MCO has built innovative integration architectures (school-based 2003; Evidence-based Practice and Innovation Center 2013; CCBHC integration; D-SNP BH integration) that competitive multi-MCO architectures may not have replicated. The MC56 substantive-contribution dimension operates strongly here.

Profile 4: Dual-eligible navigating CBH plus D-SNP plus CHC-MCO coordination in Northwest (MC56 structural)

Constituent type: PA-3 senior (age 72); dual-eligible Medicare plus Medicaid CHC; chronic depression plus history of alcohol use disorder; income approximately $19,000 (SSI plus small pension); Northwest sub-area. Triggering event: sustained BH coordination needed across Medicare D-SNP, CHC-MCO physical health, and CBH BH coverage.

Pathway through the institutional system. Constituent enrolled in CHC-MCO (Keystone First / AmeriHealth Caritas Southeast Zone per SD2 G21-SD2-03) and aligned D-SNP (per SD1 G21-SD1-04 MC54). For BH coverage, constituent is automatically a CBH member by virtue of Philadelphia residence. CBH operates CHC Team coordinating BH for senior 65+ members and members with permanent physical disabilities. Cross-plan care coordination falls on the CBH service coordinator, CHC-MCO service coordinator, and D-SNP care coordinator across three parallel managed-care interfaces.

Outcome. Constituent receives coordinated BH plus PH plus LTSS coverage at the institutional level; coordination quality depends on the three parallel service-coordinator architectures operating in alignment. The MC56 structural-concentration-risk dimension operates here: any operational disruption at CBH (financial; contracting; leadership; system) flows through to all 420,000+ Philadelphia Medicaid BH-enrolled members including this constituent with no alternative BH-MCO available. The MC56 Both/And operates: substantive integrated coordination at CBH CHC Team architecture serves this constituent AND structural single-MCO-concentration risk creates institutional-fragility profile that competitive multi-MCO architectures distribute across plans.

Conversational note

The most analytically important feature visible at SD6 is the architectural distinctiveness of Philadelphia's behavioral-health delivery. Pennsylvania's Behavioral HealthChoices program is a county-based carve-out — each county is assigned a single designated BH-MCO based on county of residence, separate from the physical-health managed-care architecture documented at SD2. Philadelphia County's assigned BH-MCO is Community Behavioral Health, a 501(c)(3) nonprofit that the City of Philadelphia DBHIDS established in February 1997 as one of the first city-operated BH-MCOs in the United States. This is structurally different from the four-PH-MCO competitive architecture at SD2: CBH operates as the sole BH-MCO for all approximately 420,000 Philadelphia Medicaid recipients; there is no member choice in BH-MCO; there is no inter-plan competition pressure; CBH has built innovative integration architectures over more than 25 years (school-based BH since 2003; Evidence-based Practice and Innovation Center 2013; CCBHC integration; D-SNP behavioral integration; CHC senior coordination team) that competitive multi-MCO architectures may not have generated AND CBH operates as a single point of accountability whose operational disruption — financial, contractual, leadership, or system — would flow through to the entire Philadelphia Medicaid BH-enrolled population with no alternative BH-MCO available. The MC56 Both/And designation captures both halves.

The most common misunderstanding about mental health parity in 2026 is that the 2024 MHPAEA Final Rule has substantially improved enforcement against commercial behavioral-health network-adequacy gaps. It has not, in 2026, in operational practice. The Tri-Agency MHPAEA Final Rule published September 9, 2024 was effective November 22, 2024 with staggered applicability for plan years beginning on or after January 1, 2025 and January 1, 2026. The Rule included new regulations for content of comparative analyses, evaluation of outcomes data, prohibitions on discriminatory factors and evidentiary standards, requirements for meaningful benefits, and effects of non-compliance — substantive expansions of the 2013 baseline parity framework. ERIC filed a lawsuit challenging the Final Rule. On May 9-15, 2025, the Trump administration Tri-Agencies announced a partial non-enforcement policy covering portions of the Final Rule applicable for plan years on or after January 1, 2025 and January 1, 2026; DOJ requested a stay of the ERIC litigation; the case is in abeyance pending the Departments' reconsideration. The 2013 Final Rule remains operative; the CAA 2021 NQTL comparative analysis requirements remain operative; the statute itself remains in place. The March 3, 2026 Tri-Agencies Fourth Annual Report to Congress demonstrates a shift in enforcement approach with DOL "not as active as they previously were" while state enforcement is growing. The MHPAEA Both/And at G21-SD6-02 operationalizes here: substantive federal parity framework continues operative at 2013 plus CAA 2021 plus statutory baseline AND structural enforcement administrative vulnerability operates at meaningful magnitude through 2026-2027 trajectory at the 2024 Final Rule expansions.

The human consequence visible in 2026 operates at three convergence points. First, the federal SAMHSA OTP / MAT Act / DEA-HHS telemedicine architecture has substantively simplified office-based buprenorphine prescribing — practitioners with DEA Schedule III registration may prescribe buprenorphine for OUD without DATA-Waiver and using permanent telemedicine flexibility, materially reducing the workforce-access bottleneck that constrained OUD treatment capacity in PA-3 for two decades. The substantive contribution of this federal architectural simplification is genuine and at meaningful magnitude. Second, the CBH single-MCO architecture has delivered innovation in school-based BH, integrated care, and senior CHC coordination that operates at meaningful population scale (100,700+ active service users in 2023 with $860M+ expenditures) — substantive contribution to PA-3 BH access at the Medicaid layer. Third, the MHPAEA 2024 Final Rule non-enforcement disposition and the broader Trump-administration SAMHSA plus CMS posture on BH/SUD architecture operate as structural enforcement-and-resourcing vulnerability at the federal-floor layer; combined with the OBBBA Medicaid disruption (SD2 G21-SD2-02) flowing through to CBH BH-MCO capitation architecture, the structural-vulnerability dimension operates at meaningful magnitude.

The most analytically important federal-engagement feature visible at SD6 is the multiplicity of trajectories operating concurrently. MHPAEA 2024 Final Rule reconsideration (Tri-Agency reexamination of enforcement program; possible modification or rescission of Final Rule portions) is the principal MHPAEA-side trajectory through 2026-2027. SAMHSA architecture under Trump-administration HHS posture affects CCBHC expansion grants, targeted-population funding, harm-reduction grant architecture, and culturally-responsive treatment funding (cross-reference D3 SD1 for SAMHSA capacity erosion). 988 funding architecture under SAMHSA annual appropriation cycles. OBBBA Medicaid delivery-side flow-through to CBH BH-MCO capitation architecture per Sections 71107 / 71109 / 71115 / 71117 / 71119 (cross-reference SD2). Federal House representation operates at each trajectory directly through appropriation, oversight, and statutory-amendment authority; PA-state-level texture engagement at PA Mental Health Parity Act enforcement, PA Behavioral HealthChoices contracting, and PA Act 98 telehealth implementation is the complementary locus.

Geography & representation

Data provenance. Pennsylvania Behavioral HealthChoices county-based carve-out architecture, the 5 BH-MCOs across 67 counties (CCBH, CBH, PerformCare, Magellan Behavioral Health of PA, Value Behavioral Health of PA), and CBH operational data (established February 1997; 100,700+ active service users in 2023; $860M+ expenditures; approximately 420,000 Medicaid recipients covered; CEO Donna E.M. Bailey, MSEd, MBA) are documented in DBHIDS official communications and Pew Charitable Trusts reporting. MHPAEA statute (29 U.S.C. § 1185a; 42 U.S.C. § 300gg-26), CAA 2021 § 203 NQTL comparative-analysis requirement, the 2024 Final Rule (89 Fed. Reg. 77586 September 23, 2024), and the Tri-Agency non-enforcement statement May 9-15, 2025 are documented in federal statutory and regulatory record. ERIC v. DOL/HHS/Treasury in abeyance May 12, 2025 before Judge Timothy J. Kelly D.D.C. is documented in D.D.C. court records. SAMHSA 42 C.F.R. Part 8 Final Rule (89 Fed. Reg. 7528 February 2, 2024; correction 91 Fed. Reg. 7456 February 23, 2026) is documented in HHS Federal Register record. MAT Act / Section 1262 CAA 2023 P.L. 117-328 is in federal statutory record. DEA-HHS permanent telemedicine flexibility 2025 is documented in DEA / HHS Federal Register record. National Suicide Hotline Designation Act of 2020 P.L. 116-172 is in federal statutory record. PA Mental Health Procedures Act of 1976 (50 P.S. § 7101 et seq.), PA Mental Health Parity Act PA Act 50 of 2004 (40 P.S. § 908-1 et seq.), and PA Act 98 of 2022 telehealth permanence are documented in PA statutory record. The Shapiro 2026-27 budget proposal for 15% increase to $4.4 billion in Medicaid capitation funding for behavioral and physical HealthChoices programs combined is documented in PA executive budget materials. PA-3 sub-area-disaggregated BH/SUD treatment utilization, OTP geographic distribution, office-based buprenorphine prescriber concentration, and inpatient psychiatric bed capacity are flagged for institutional retrieval.

PA-3 statistical profile. CBH covers approximately 420,000 Philadelphia Medicaid recipients by virtue of the carve-out architecture; 100,700+ used CBH services in 2023 (the difference reflects the auto-enrollment architecture — all Philadelphia Medicaid recipients are CBH members regardless of whether they use BH services in a given year). CBH 2023 total expenditures $860,000,000+; 2018 budget over $900M plus assets over $160M. Pennsylvania operates BH-MCO carve-out across 67 counties through 5 BH-MCO organizations: CCBH (western and central PA including Allegheny, Berks, Centre, Chester); CBH (Philadelphia County exclusively); PerformCare (Capital Region: Cumberland, Dauphin, Franklin, Lancaster, Lebanon, Perry); Magellan Behavioral Health of PA (Lehigh, Northampton, northeastern counties); Value Behavioral Health of PA (rural central and northern). 2026-27 PA budget proposes 15% increase to $4.4 billion in Medicaid capitation funding for behavioral and physical HealthChoices programs combined. MHPAEA 2024 Final Rule effective November 22, 2024 with staggered applicability for plan years on/after January 1, 2025 and January 1, 2026; Trump-administration partial non-enforcement policy May 9-15, 2025; March 3, 2026 Tri-Agencies Fourth Report documents DOL "not as active as previously."

Geographic variation.

• North/Northwest Philadelphia Core. Friends Hospital (4641 Roosevelt Boulevard) and Belmont Behavioral Health (4200 Monument Road) are the principal inpatient psychiatric capacity. Cumulative-disadvantage geography concentration interacts with CBH school-based BH program access through SDP buildings.
• West Philadelphia Core. Penn Medicine inpatient psychiatric (HUP, Penn Presbyterian, Pennsylvania Hospital) plus CHOP pediatric psychiatric provide academic-medical-center BH capacity. Anchor-institution-employee paradox carries ERISA-preempted MHPAEA enforcement profile (cross-reference SD3 G21-SD3-04).
• Northwest Philadelphia. Belmont Behavioral Health located here; Einstein (Jefferson Einstein post-merger) provides additional BH capacity. Internally heterogeneous BH utilization patterns.
• South/Southwest Philadelphia. Jefferson psychiatric and Pennsylvania Hospital provide BH capacity; documented immigrant-population concentration interacts with 42 C.F.R. Part 2 SUD record confidentiality and culturally-responsive BH access architecture.

PA-3 sub-area-disaggregated BH/SUD treatment utilization, OTP geographic distribution, office-based buprenorphine prescriber concentration, inpatient psychiatric bed capacity, and CBH service utilization are not retrievable at four-sub-area resolution from public-facing data products.

Gap analysis

Six structural gaps recur across the constituent profiles and the architectural layers above.

G21-SD6-01 — CBH city-of-Philadelphia-contracted single BH-MCO architecture: substantive innovation plus structural single-MCO concentration risk (MC56 Both/And). Substantive contribution: Pennsylvania's Behavioral HealthChoices county-based carve-out architecture assigns Philadelphia County exclusively to CBH, a 501(c)(3) nonprofit contracted by the City of Philadelphia DBHIDS since February 1997 as one of the first city-operated BH-MCOs in the United States. CBH operational scale: 100,700+ active service users (2023); $860,000,000+ total expenditures (2023); approximately 420,000 Medicaid recipients covered. CBH innovation architecture documented: school-based BH program (launched 2003); Evidence-based Practice and Innovation Center (launched 2013); CCBHC integration; D-SNP behavioral integration; CHC Team for senior 65+ and permanent-disability members. Structural single-MCO concentration risk: No member choice in BH-MCO at the county level — all Philadelphia HealthChoices enrollees auto-enrolled in CBH regardless of PH-MCO selection; no inter-plan competition pressure on network adequacy, formulary, or prior authorization standards within Philadelphia BH market; any operational disruption at CBH flows through to all 420,000+ Philadelphia Medicaid BH-covered members with no alternative BH-MCO available; OBBBA Section 71117 MCO-tax tightening effective July 4, 2025 plus OBBBA Section 71115 provider-tax safe-harbor stepdown flow-through to CBH capitation architecture creates fiscal-pressure profile. Representation implication: PA-state-level engagement at PA OMHSAS Behavioral HealthChoices contracting and rate-setting is the principal texture-level locus; federal House representation engagement at OBBBA technical corrections affecting BH-MCO capitation architecture and at CMS Medicaid managed-care oversight is direct.

G21-SD6-02 — MHPAEA 2024 Final Rule Trump-administration partial non-enforcement policy operational impact on PA-3 commercial-coverage BH access (MHPAEA Both/And). MHPAEA statute requires parity between MH/SUD benefits and medical/surgical benefits in commercial group health plans, ACA marketplace plans, Medicare Advantage, and Medicaid managed care. The 2024 Tri-Agency Final Rule effective November 22, 2024 with staggered applicability for plan years on/after January 1, 2025 and January 1, 2026 included new NQTL comparative analysis content requirements, meaningful benefits standard, prohibitions on discriminatory factors and evidentiary standards, and relevant data evaluation requirements. ERIC v. DOL/HHS/Treasury filed in U.S. District Court for the District of Columbia (Judge Timothy J. Kelly) challenging Final Rule; case in abeyance May 12, 2025. Trump administration partial non-enforcement policy May 9-15, 2025 covering portions of 2024 Final Rule "new in relation to 2013 Final Rule" until final decision in ERIC litigation plus 18 months. 2013 Final Rule plus CAA 2021 NQTL requirements plus statute itself remain operative. March 3, 2026 Tri-Agencies Fourth Report to Congress documents DOL "not as active as previously" with state enforcement growing. Representation implication: Federal House representation has direct legislative authority on MHPAEA statutory amendments; oversight authority on Tri-Agency enforcement architecture and 2024 Final Rule reconsideration trajectory.

G21-SD6-03 — SAMHSA 42 C.F.R. Part 8 OTP architecture plus MAT Act DATA-Waiver elimination plus DEA-HHS permanent telemedicine flexibility substantive simplification. SAMHSA 42 C.F.R. Part 8 Final Rule (February 2, 2024; effective April 2, 2024; compliance October 2, 2024; correction February 23, 2026) codifies COVID-era OTP flexibilities permanently — take-home doses up to 28 days methadone for stable patients / 14 days for less stable; telehealth screening for buprenorphine initiation; audio-only and audio-visual platforms subject to HIPAA-compliance. MAT Act / Section 1262 CAA 2023 eliminated DATA-Waiver requirement for buprenorphine OUD prescribing effective January 2023; DEA Schedule III registration sufficient. DEA-HHS permanent telemedicine flexibility for buprenorphine OUD prescribing finalized 2025. PA Act 98 of 2022 permits audio-only telehealth in PA outpatient drug-and-alcohol clinic services. The substantive federal architectural simplification operates at meaningful magnitude reducing workforce-access bottleneck for office-based buprenorphine prescribing. Representation implication: Federal House representation engagement at SAMHSA appropriation, CCBHC expansion grants, and 988 funding; SAMHSA administrative posture under Trump HHS is the principal forward-trajectory variable.

G21-SD6-04 — 988 Suicide and Crisis Lifeline PA-3 implementation status. National Suicide Hotline Designation Act of 2020 authorized 988 as nationwide 3-digit dialing code; SAMHSA implements through Vibrant Emotional Health contract; nationwide operational July 16, 2022. PA mobile crisis architecture coordinates with CBH for Medicaid-enrolled callers and DBHIDS for non-Medicaid callers. PA-3-specific 988 call volume, routing-to-mobile-crisis architecture, and crisis-line workforce capacity flagged for retrieval. Cross-reference D3 SD7 for the Philadelphia Crisis Line (PCL) operating as the only locally-based 988 response team in the country, the CMCRT plus CIRT post-2021 Crisis 2.0 architecture, and the substantive crisis-infrastructure analysis. Representation implication: Federal House representation engagement at SAMHSA 988 appropriation; federal-state crisis-line architecture coordination.

G21-SD6-05 — BH-PH care coordination gap at CBH carve-out plus PH-MCO plus CHC-MCO plus D-SNP interfaces. The PA carve-out architecture creates parallel managed-care interfaces for PA-3 dual-eligibles and complex-care patients: CBH (BH carve-out) operates separately from PH-MCO (HealthChoices Physical Health) and CHC-MCO (Community HealthChoices LTSS), with D-SNP behavioral integration adding a fourth interface layer (cross-reference SD1 G21-SD1-04 MC54). The cross-plan care-coordination burden falls on the beneficiary or care manager rather than on the plans. Cross-reference SD2 G21-SD2-06 for substantive structural-feature analysis. Representation implication: PA-state-level engagement at OMHSAS cross-MCO coordination requirements; federal CMS engagement at Medicaid managed-care care-coordination standards and at MHPAEA enforcement.

G21-SD6-06 — PA-3 sub-area-disaggregated BH/SUD treatment utilization and infrastructure data gap. PA-3 sub-area-disaggregated BH/SUD treatment utilization, OTP geographic distribution, office-based buprenorphine prescriber concentration, inpatient psychiatric bed capacity, and CBH service utilization are not retrievable at four-sub-area resolution from public-facing data products. Representation implication: Federal House representation engagement at SAMHSA data products; state engagement at CBH and DBHIDS data publication architecture.

Where this leads

Federal House representation operates at four principal SD6 trajectories simultaneously: MHPAEA 2024 Final Rule reconsideration (Tri-Agency reexamination; possible modification, rescission, or partial reissuance); SAMHSA architecture under Trump-administration HHS posture (CCBHC expansion grants; targeted-population funding; harm-reduction grant architecture; 988 funding); OBBBA Medicaid delivery-side flow-through to CBH BH-MCO capitation architecture (Sections 71107 / 71109 / 71115 / 71117 / 71119); and DEA-HHS / SAMHSA OTP architecture continued maintenance under Trump-administration HHS. PA-state-level texture engagement at PA Insurance Department PA Mental Health Parity Act enforcement, PA OMHSAS Behavioral HealthChoices contracting, and PA Act 98 telehealth implementation is the principal complementary locus.

The MC56 Both/And captures the central analytical posture at SD6: substantive CBH single-MCO innovation architecture serves PA-3 Medicaid BH-enrolled population at meaningful magnitude AND structural single-MCO-concentration risk operates at the institutional-fragility profile that competitive multi-MCO architectures distribute across plans. The MHPAEA Both/And at G21-SD6-02 captures the parallel posture at the federal commercial-side parity layer.

The next sub-domain — Specialty Clinical and Cross-Cutting Delivery — closes the D21 architecture at the convergence of six concurrent federal-policy-cycle mechanisms (IIJA reauthorization; 340B post-vacatur; Title X disruption; Medicare telehealth post-2027; OBBBA flow-through; MHPAEA non-enforcement) plus three cross-domain principal-anchor deferrals from D13 and secondary cross-references to D6, D2, D9, D10, D11, D24. The Telehealth Both/And at G21-SD7-04 carries the forward MC62 candidate designation.